marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Altimmune Balance Sheet 2011-2024 | ALT
Annual Balance Sheet Altimmune
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-134 M | -110 M | -188 M | -114 M | -7.22 M | -33.1 M | -8.12 M | -153 M | -15.6 M | -17.9 M | -7.66 M | -8.92 M | -11.2 M |
Long Term Debt |
175 K | 672 K | 1.45 M | - | - | 501 K | 600 K | - | - | - | 730 K | 1.7 M | - |
Long Term Debt Current |
496 K | 452 K | 411 K | 357 K | 259 K | - | - | - | - | 746 K | 1 M | 750 K | - |
Total Non Current Liabilities |
4.4 M | 4.58 M | - | 7.22 M | 4.61 M | 1.91 M | 10.5 M | 443 K | 1.03 M | 1.12 M | 3.01 M | 3.58 M | 2.34 M |
Total Current Liabilities |
12.1 M | 17.1 M | 18.3 M | 12 M | 3.92 M | 4.53 M | 3.84 M | 205 M | 2.18 M | 2.58 M | 6.8 M | 7.49 M | 4.62 M |
Total Liabilities |
16.5 M | 21.6 M | 19.7 M | 19.2 M | 8.54 M | 6.44 M | 14.4 M | 205 M | 3.21 M | 3.7 M | 9.8 M | 11.1 M | 6.95 M |
Deferred Revenue |
- | - | - | 19.8 K | 61.6 K | 19.8 K | 19.8 K | - | - | - | 342 K | 1.38 M | - |
Retained Earnings |
-466 M | -378 M | -293 M | -186 M | -137 M | -117 M | -77.7 M | -29.9 M | -224 M | -220 M | -210 M | -199 M | -194 M |
Total Assets |
211 M | 207 M | 219 M | 245 M | 54.1 M | 54.8 M | 63 M | 225 M | 19.9 M | 22 M | 17.1 M | 22.7 M | 22.8 M |
Cash and Cash Equivalents |
135 M | 111 M | 190 M | 116 M | 8.96 M | 33.7 M | 8.77 M | 154 M | 15.6 M | 18.6 M | 10.5 M | 12.7 M | 11.2 M |
Book Value |
194 M | 185 M | 199 M | 226 M | 45.5 M | 48.3 M | 48.7 M | 19.5 M | 16.6 M | 18.3 M | 7.34 M | 11.7 M | 15.9 M |
Total Shareholders Equity |
194 M | 185 M | 199 M | 226 M | 45.5 M | 48.3 M | 39.4 M | 32.2 M | 16.6 M | 18.3 M | 7.34 M | 11.7 M | 15.9 M |
All numbers in USD currency
Quarterly Balance Sheet Altimmune
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.46 M | 1.52 M | 175 K | 4.3 M | 4.16 M | 4.4 M | 4.58 M | 4.51 M | 1.53 M | 1.67 M | 1.45 M | 1.57 M | 1.62 M | 1.72 M | 1.83 M | 1.83 M | 1.83 M | 1.83 M | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 1.85 M | 1.85 M | 1.85 M | 1.85 M | 600 K | 590 K | 571 K | - | 526 K | - | 526 K | - | - | - | - | - | - | 993 K | 240 K | 485 K | 730 K | 730 K | 730 K | 730 K | 1.7 M | 1.7 M | 1.7 M | 1.7 M | - | - | - | - |
Total Non Current Liabilities |
5.85 M | 5.66 M | 4.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
14.5 M | 20.8 M | 16.5 M | 16.2 M | 15.6 M | 19.4 M | 21.6 M | 20.2 M | 15.4 M | 20.8 M | 19.7 M | 27.6 M | 16 M | 17.8 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 8.54 M | 8.54 M | 8.54 M | 8.54 M | 6.44 M | 6.44 M | 6.44 M | 6.44 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 6.19 M | 6.19 M | 6.19 M | 205 M | 3.21 M | 3.21 M | 3.21 M | 3.21 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 9.8 M | 9.8 M | 9.8 M | 9.8 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 6.95 M | 6.95 M | 6.95 M | 6.95 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 19.8 K | 58 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 61.6 K | 61.6 K | 61.6 K | 61.6 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | 19.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-538 M | -515 M | -466 M | -435 M | -414 M | -398 M | -378 M | -356 M | -333 M | -313 M | -293 M | -269 M | -236 M | -211 M | -186 M | -186 M | -186 M | -186 M | -137 M | -137 M | -137 M | -137 M | -117 M | -117 M | -117 M | -117 M | -77.7 M | -77.7 M | -77.7 M | -77.7 M | -31.3 M | -31.3 M | -31.3 M | -29.9 M | -224 M | -224 M | -224 M | -224 M | -220 M | -220 M | -220 M | -220 M | -210 M | -210 M | -210 M | -210 M | -199 M | -199 M | -199 M | -199 M | -194 M | -194 M | -194 M | -194 M |
Total Assets |
148 M | 173 M | 211 M | 167 M | 183 M | 187 M | 207 M | 225 M | 210 M | 206 M | 219 M | 237 M | 257 M | 264 M | 245 M | 245 M | 245 M | 245 M | 54.1 M | 54.1 M | 54.1 M | 54.1 M | 54.8 M | 54.8 M | 54.8 M | 54.8 M | 63 M | 63 M | 63 M | 63 M | 38.4 M | 38.4 M | 38.4 M | 225 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 22 M | 22 M | 22 M | 22 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 22.7 M | 22.7 M | 22.7 M | 22.7 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M |
Cash and Cash Equivalents |
31.5 M | 57.1 M | 135 M | 86.9 M | 102 M | 105 M | 111 M | 127 M | 136 M | 180 M | 190 M | 175 M | 174 M | 150 M | 116 M | 116 M | 116 M | 116 M | 8.96 M | 8.96 M | 8.96 M | 8.96 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 8.77 M | 8.77 M | 8.77 M | 8.77 M | 2.88 M | 2.88 M | 2.88 M | 154 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M |
Book Value |
133 M | 153 M | 194 M | 150 M | 168 M | 168 M | 185 M | 205 M | 195 M | 185 M | 199 M | 209 M | 241 M | 246 M | 226 M | 226 M | 226 M | 226 M | 45.5 M | 45.5 M | 45.5 M | 45.5 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 48.7 M | 48.7 M | 48.7 M | 48.7 M | 32.2 M | 32.2 M | 32.2 M | 19.5 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 7.34 M | 7.34 M | 7.34 M | 7.34 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 15.9 M | 15.9 M | 15.9 M | 15.9 M |
Total Shareholders Equity |
133 M | 153 M | 194 M | 150 M | 168 M | 168 M | 185 M | 205 M | 195 M | 185 M | 199 M | 209 M | 241 M | 246 M | 226 M | 226 M | 226 M | 226 M | 45.5 M | 45.5 M | 45.5 M | 45.5 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 32.2 M | 32.2 M | 32.2 M | 19.5 M | 43.1 M | 16.6 M | 16.6 M | 16.6 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 7.34 M | 7.34 M | 7.34 M | 7.34 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 15.9 M | 15.9 M | 15.9 M | 15.9 M |
All numbers in USD currency